School of Pediatrics, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
Department of Surgery, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Int Wound J. 2023 Oct;20(8):3298-3306. doi: 10.1111/iwj.14210. Epub 2023 May 23.
A meta-analysis investigation was executed to measure the outcome of sutured wounds (SWs) compared with tissue adhesive (TA) for paediatric wound closure (PWC). A comprehensive literature inspection till February 2023 was applied and 2018 interrelated investigations were reviewed. The 18 chosen investigations enclosed 1697 children with PWC in the chosen investigations' starting point, 977 of them were utilising SWs, and 906 were utilising TA. Odds ratio (OR) in addition to 95% confidence intervals (CIs) were used to compute the value of the effect of SWs compared with TA for PWC by the dichotomous approaches and a fixed or random model. SWs had significantly higher wound cosmetic (WC) scores (mean deviation [MD], 1.70; 95% CI, 0.57-2.84, P = .003), lower wound dehiscence (WD) (OR 0.60; 95% CI, 0.06-0.43, P < .001), and lower cost (MD, -10.22; 95% CI, -10.94 to -9.50, P < .001) compared with those with TA in PWC. No significant difference was found between children utilising SWs and TA in wound infection (WI) (OR, 0.45; 95% CI, 0.15-1.30, P = .14) with no heterogeneity (I = 0%) in PWC. SWs had significantly higher WC scores, lower WD, and lower cost, yet, no significant difference was found in WI compared with those with TA in PWC. However, care must be exercised when dealing with its values because of the low sample size of some of the nominated investigations and the low number of selected investigations for the meta-analysis.
一项荟萃分析研究旨在衡量缝合伤口 (SWs) 与组织粘合剂 (TA) 在小儿伤口闭合 (PWC) 中的效果。对 2018 年相关研究进行了回顾。18 项选定的研究纳入了 1697 例小儿 PWC 患者,其中 977 例使用 SWs,906 例使用 TA。采用二项式方法和固定或随机模型,使用比值比 (OR) 及其 95%置信区间 (CI) 计算 SWs 与 TA 比较在 PWC 中的效果值。SWs 在伤口美容 (WC) 评分上具有显著优势 (平均差值 [MD],1.70;95%CI,0.57-2.84,P = .003),伤口裂开 (WD) 发生率较低 (OR 0.60;95%CI,0.06-0.43,P < .001),成本较低 (MD,-10.22;95%CI,-10.94 至 -9.50,P < .001),而与 TA 组相比。在 PWC 中,使用 SWs 和 TA 的患儿在伤口感染 (WI) 方面无显著差异 (OR,0.45;95%CI,0.15-1.30,P = .14),且无异质性 (I = 0%)。SWs 在 WC 评分、WD 和成本方面具有显著优势,但在 WI 方面与 TA 组无显著差异。然而,在处理这些结果时需要谨慎,因为一些提名研究的样本量较小,而且用于荟萃分析的选定研究数量较少。